. Involvement of Na ϩ /Ca 2ϩ exchanger in endothelial NO production and endothelium-dependent relaxation. Am J Physiol Heart Circ Physiol 283: H837-H844, 2002. First published April 18, 2002 10.1152/ajpheart.00789.2001.-Endothelial nitric oxide (NO) synthase (eNOS) is controlled by Ca 2ϩ /calmodulin and caveolin-1 in caveolae. It has been recently suggested that Na ϩ /Ca 2ϩ exchanger (NCX), also expressed in endothelial caveolae, is involved in eNOS activation. To investigate the role played by NCX in NO synthesis, we assessed the effects of Na ϩ loading (induced by monensin) on rat aortic rings and cultured porcine aortic endothelial cells. Effect of monensin was evaluated by endothelium-dependent relaxation of rat aortic rings in response to acetylcholine and by real-time measurement of NO release from cultured endothelial cells stimulated by A-23187 and bradykinin. Na ϩ loading shifted the acetylcholine concentration-response curve to the left. These effects were prevented by pretreatment with the NCX inhibitors benzamil and KB-R7943. Monensin potentiated Ca 2ϩ -dependent NO release in cultured cells, whereas benzamil and KB-R7943 totally blocked Na ϩ loading-induced NO release. These findings confirm the key role of NCX in reverse mode on Ca 2ϩ -dependent NO production and endothelium-dependent relaxation. ] i is mainly dependent on plasma membrane Ca 2ϩ -ATPase (23, 34), which has a high affinity for Ca 2ϩ but a low turnover rate, and Na ϩ /Ca 2ϩ exchanger (NCX), which transports Ca 2ϩ outside the cell in forward mode and inside the cell in reverse mode with lower affinity but a higher turnover rate. In forward mode, NCX operates in parallel with the plasma membrane Ca 2ϩ -ATPase pump to maintain Ca 2ϩ homeostasis. Na ϩ /Ca 2ϩ exchange current has been reported in heart cells (16), arterial smooth muscle cells (14, 29) , and more recently in endothelial cells by Kaye and Kelly (15), where NCX is thought to contribute to endothelium-dependent control of contraction and relaxation (1, 7). The NCX inhibitor dichlorobenzamil decreased endothelium-dependent relaxation of vascular smooth muscle without affecting endothelium-independent relaxation caused by the NO donor sodium nitroprusside (33, 41) . These results supported the involvement of the reverse mode of Na ϩ /Ca 2ϩ exchange in the release of endotheliumderived NO. Recently, Teubl et al. (37) demonstrated the effect of intracellular Na ϩ load in the Ca 2ϩ -dependent activation of eNOS and suggested the involvement of NCX in the caveolae-associated cell signaling. However, endothelium-dependent relaxation involves not only NO but also endothelium-derived hyperpolarizing factor (EDHF) (5, 24), suggesting that real-time measurement of endothelial cell NO release might confirm the involvement of NCX in Ca 2ϩ -dependent NO synthesis. Direct measurement of NO release may be evaluated by chemiluminescence (27) and electrochemistry with polarographic electrode (20) . Recently, new generations of amperometric sensors have allowed
IN ENDOTHELIAL CELLS, nitric oxide (NO) is synthesized by Ca 2ϩ
/calmodulin-dependent NO synthase (NOS) [endothelial NOS (eNOS)]. The activity of the enzyme is tightly controlled by its interaction with caveolin-1 in a specialized domain of the membrane, namely the caveolae. An increase in intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) dissociated the NOS III-caveolin 1 complex and induced action of the NOS III-Ca 2ϩ /calmodulin complex (9, 13, 21) . Numerous intermediates are involved in the main signal transduction pathway of agonist-stimulated eNOS activation. For example, NO synthesis is regulated by serine/threonine kinases, including cAMP-dependent protein kinase (3, 4) , protein kinase C (26, 30) , Ca 2ϩ /calmodulin protein kinase II (38) , and protein kinase B/Akt (6, 8) . In addition to phosphorylation, Ca 2ϩ -dependent regulation of eNOS also involves an increase in subplasmalemmal [Ca 2ϩ ] i , supporting the role of local distribution of Ca 2ϩ in caveolaes (10, 28) . The subplasmalemmal [Ca 2ϩ ] i is mainly dependent on plasma membrane Ca 2ϩ -ATPase (23, 34) , which has a high affinity for Ca 2ϩ but a low turnover rate, and Na ϩ /Ca 2ϩ exchanger (NCX), which transports Ca 2ϩ outside the cell in forward mode and inside the cell in reverse mode with lower affinity but a higher turnover rate. In forward mode, NCX operates in parallel with the plasma membrane Ca 2ϩ -ATPase pump to maintain Ca 2ϩ homeostasis. Na ϩ /Ca 2ϩ exchange current has been reported in heart cells (16) , arterial smooth muscle cells (14, 29) , and more recently in endothelial cells by Kaye and Kelly (15) , where NCX is thought to contribute to endothelium-dependent control of contraction and relaxation (1, 7) . The NCX inhibitor dichlorobenzamil decreased endothelium-dependent relaxation of vascular smooth muscle without affecting endothelium-independent relaxation caused by the NO donor sodium nitroprusside (33, 41) . These results supported the involvement of the reverse mode of Na ϩ /Ca 2ϩ exchange in the release of endotheliumderived NO. Recently, Teubl et al. (37) demonstrated the effect of intracellular Na ϩ load in the Ca 2ϩ -dependent activation of eNOS and suggested the involvement of NCX in the caveolae-associated cell signaling. However, endothelium-dependent relaxation involves not only NO but also endothelium-derived hyperpolarizing factor (EDHF) (5, 24) , suggesting that real-time measurement of endothelial cell NO release might confirm the involvement of NCX in Ca 2ϩ -dependent NO synthesis. Direct measurement of NO release may be evaluated by chemiluminescence (27) and electrochemistry with polarographic electrode (20) . Recently, new generations of amperometric sensors have allowed high-sensitivity real-time detection of NO. The present study was designed to specify the role of monensininduced Na ϩ loading in endothelium-dependent relaxation of the rat aorta. NCX involvement was also confirmed by direct measurement of NO release in cultured porcine aortic endothelial cells (PAECs).
MATERIALS AND METHODS
Drugs. Reagents were from Sigma and RBI, distributed by Sigma (Saint-Quentin Fallavier, France) unless otherwise stated. The Na ϩ ionophore monensin and the selective blocker of the Na ϩ /Ca 2ϩ channel benzamil hydrochloride (N-benzylamidino-3,5-diamino-6-chloropyrazinecarboxamide) were dissolved in ethanol. Phenylephrine hydrochloride (␣1-adrenergic agonist), acetylcholine chloride (ACh; muscarinic agonist), calcium ionophore A-23187, sodium nitroprusside (NO donor), and N -nitro-L-arginine methyl ester hydrochloride (L-NAME; analog of arginine and competitive, isozyme nonselective, NOS inhibitor) were made up in bidistilled deionized water. Each was made freshly every day and protected from light. All other drugs were dissolved in bidistilled deionized water except indomethacin, which was dissolved in ethanol. Further dilutions were made in Krebs solution (see Tissue preparation and tension measurement for composition) for in vitro experiments. The drug solutions were prepared each day from dry powder.
Tissue preparation and tension measurement. All animal procedures were applied in accordance with the European directives for animal experiments 86/609 (Centre National de la Recherche Scientifique, Paris, France). At the time of experimentation, adult male Sprague-Dawley rats (251-275 g, Charles River; Saint-Aubin Les Elbeufs, France) were anesthetized with thiopental sodium (Nesdonal; 80 mg/kg ip) and heparinized (100 IU ic). After a thoracotomy, the aorta was excised en bloc in cold Krebs balanced salt solution [composed of (in mM) 118 NaCl, 5.9 KCl, 1.2 MgSO4 ⅐ 7H2O, 1.2 NaH 2PO4 ⅐ 2H2O, 2.5 CaCl2 ⅐ 2H2O, 25.5 NaHCO3, and 5.6 D-glucose] containing 1 mM indomethacin. The thoracic aorta of internal diameter 2.5 Ϯ 0.2 mm was isolated clean of adherent fat and connective tissue and cut into rings of 3.0 mm in length. Two L-shaped stainless steel wires were inserted into the arterial lumen, and the rings were suspended in a 20-ml tissue bath. One stainless steel holder was attached to the chamber, and the other to an isometric forcedisplacement transducer (Emka Technologie; Paris, France). Temperature of the organ chambers was kept constant at 37°C in Krebs buffer solution gassed with 95% O2-5% CO2 (Air Liquide santé; Paris, France). The tension was recorded with the isometric force transducer connected to a data processing system (MacLab /8e, ADInstruments; Paris, France). The rings were set at an initial resting tension of 1.5 g (the resting tension had been previously determined to be the optimal tension for length development in response to 60 mM KCl) and allowed to equilibrate for 60 min, with the rings being repeatedly washed every 15 min. Verification of endothelium integrity was performed by testing the vascular relaxation produced in phenylephrine (0.1 M)-precontracted rings by the endothelium-dependent vasodilator ACh (0.1 M). In the experiments with endothelium-denuded rat aortic rings, the endothelial cell layer was removed by rubbing the luminal surface of the vessel with a cotton swab. After equilibration, the vascular rings were submaximally precontracted with 0.1-1 M phenylephrine, and stepwise pharmacological sequence was initiated.
Characterization of the pharmacological responsiveness of aortic rings. At the plateau phase, concentration-relaxation curves to ACh (0.001-10 M) were constructed by increasing the concentration in the organ chamber in cumulative increments after a steady-state response had been reached with each increment on precontracted rings with phenylephrine (1 M). After the highest concentration of ACh, the rings were totally relaxed by sodium nitroprusside (0.1 mM). In preincubated experiments, monensin (final concentrations: 1 and 10 M) or benzamil (1 M) ϩ monensin (1 M) were added to the bath at the plateau phase, and relaxation was proceeded after equilibration with the tissue for 15 min. Controls were determined by the addition of vehicle/Krebs balanced salt solution or 0.01% ethanol.
Histology. Endothelium integrity was assessed by postpharmacological challenge histology analysis. Tissues were harvested, fixed in 10% neutral buffered formaldehyde, embedded in paraffin, and sectioned. Histological sections (5 m thick) were stained with hematoxylin and eosin (Sigma) and examined.
Endothelial cell culture. All the reagents used for cell culture were from GIBCO-BRL (Cergi-Pontoise, France) if not otherwise specified. The PAEC line established by Malassagne et al. (1998) (19) was a gift from B. Weill (Laboratoire d'Immunologie, Paris, France). PAECs were cultured into 25-cm 2 Primaria dishes (Polylabo; Paris, France) in RPMI 1640 medium-glutamax-1 supplemented with 100 U/ml penicillin, 100 g/ml streptomycin, 50 g/ml amphotericine B, and 10% fetal bovine serum. The cultures were incubated at 37°C in a humid atmosphere with 5% CO 2. When cells reached confluence, they were detached by incubation with 0.05% trypsin-EDTA in RPMI 1640 medium-glutamax-1 for 3 min at 37°C, centrifuged at 300 g for 10 min, suspended in fresh complete medium, and further cultured under the same conditions. Cells were characterized as endothelial cells by Fig. 1 . Potentiation of endothelium-dependent relaxation to acetylcholine by the Na ϩ ionophore monensin. Concentration-response curves for the vasorelaxation effect of acetylcholine (10 Ϫ9 -10 Ϫ5 M) on phenylephrine-contracted aortic rings with endothelium are shown. Effects of monensin (1 and 10 M) compared with vehicle (0.01% ethanol) as the control (n ϭ 6) are also shown. Monensin (1 and 10 M) was added at the plateau evoked by the ␣1-adrenergic agonist and incubated 15 min before acetylcholine challenge. Results are expressed as percentages of maximal relaxation and are presented as means Ϯ SE. **P Ͻ 0.01 and *P Ͻ 0.05, significant differences between monensin-and vehicle-treated preparations. their morphology, their ability to take up acetylated lowdensity lipoproteins (25) , the detection of von Willebrand factor (27) , and expression of E-selectin (19) .
Cell stimulation. Four sets of transfected PAECs (between passages 25 and 28) were tested. The cells were subcultured in 24-well flat-bottom culture plates (10 5 cells/well) during 24 h to reach confluence. The culture medium was removed, and the cells were equilibrated in isotonic phosphate buffer (pH 7.4) containing 8 mM Na 2HPO4, 1.5 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, 0.9 mM CaCl2, 1 mM MgCl2, and 1 mM indomethacin and oxygenated with 95% O2-5% CO2 (Air Liquide santé). The hypotonic low-Na ϩ phosphate buffer contained 100 mM NaCl. After equilibration, the sensor probe was inserted vertically into a well with confluent cells, the sensor membrane was positioned 50 M above the monolayer using a manual micromanipulator, and the well was sealed. The distance between the sensor membrane and the monolayer was determined after a distance-response curve; it corresponded to the maximal signal without leak current. To investigate the response to the agonists, the cells were stimulated with either A-23187 (10 Ϫ9 -10 Ϫ4 M) or bradykinin (10 Ϫ10 -10 Ϫ5 M), and the concentration-response curve was plotted as the control. The effect of NCX was evaluated on the concentration-response curve for A-23187 or bradykinin of cells previously incubated with monensin (1 and 10 M), benzamil (1 mM), or benzamil (1 mM) ϩ monensin (10 M). The endothelial cells were incubated for 30 min and stimulated by A-23187 (10 Ϫ9 -10 Ϫ4 M) or bradykinin (10 Ϫ10 -10 Ϫ5 M) with the same experimental procedure as the control.
Electrochemical detection of NO. S-nitroso-N-acetyl-D,Lpenicillamine (SNAP), CuCl, EDTA, and NaOH were obtained from Sigma and Fluka. All of the solutions were dissolved in deoxygenated bidistilled water. Amperometric measurements of released NO were quantified with a Clarktype electrode (2-mm platinum disk NO sensor: Iso-NOP, World Precision Instruments; Stevenage, UK) connected to a Iso Mark II NO meter (World Precision Instruments). The newly developed electrode has a high selectivity for NO and a detection sensitivity of 1 nM. The principle of measurement has previously been described (35) . NO diffusing through the gas-permeable membrane is oxidized at the working platinum electrode. The resulting redox current is proportional to the concentration of NO gas in aqueous solution. The analyzer was connected to an Apple Macintosh computer-based data-acquisition system via an analog-to-digital converter (MacLab /8e, ADInstruments). The output current was recorded at a constant laboratory temperature (23°C). The calibration of the electrode was performed daily according to the procedure described by Zhang et al. (42) .
Data analysis. All responses to phenylephrine are expressed as force (in g). Responses to vasodilator agents are expressed as a percentage of maximal relaxation. In the endothelium-intact vessels, effects of NCX inhibitors were repeatedly measured on two or three rings for each aorta, and the values were averaged. For all experiments of relaxation, n represents the number of animals. EC 50 represents the concentration (in M) of agonist required for half-maximal relaxation. Sensitivity to the agonists in different conditions is expressed in term of pD 2 [pD2 ϭ Ϫlog(EC50)]. Data are expressed as means Ϯ SE of n experiments; sample size is systematically indicated. Results were analyzed using one-way ANOVA to compare the effects of inhibitors versus control. When the F value for an effect was globally significant, comparisons were made using a Mann-Whitney U-test. In stimulated PAECs, NO concentration was expressed in nanomolars. Effects of monensin and NCX inhibitors were repeatedly measured on two or three wells, and the values were averaged; n represents the number of cultured plates. The baseline was automatically established by the Iso Mark II NO meter. Statistical evaluation of the difference between pretreated PAECs and control was assessed with Student's two-tailed t-test. All statistical tests were considered as significant for an ␣-level below 0.05. Computation was performed with the Statistica software (Statsoft; Maison-Alfort, France).
RESULTS

Effect of the Na
ϩ ionophore monensin on endothelium-dependent relaxation to acetylcholine. In phenylephrine-precontracted endothelium-intact rings, ACh (10 Ϫ9 -10 Ϫ5 M) induced concentration-dependent relaxation (pD 2 ϭ 6.52 Ϯ 0.38, n ϭ 5) (Fig. 1) . L-NAME (0.05 mM) totally inhibited the ACh-evoked relaxation. Pretreatment of the rat aortic rings with monensin (1 and 10 M) resulted in a leftward shift of the concentration-response curves (pD 2 ϭ 6.92 Ϯ 0.21, n ϭ 4, and pD 2 ϭ 6.89 Ϯ 0.18, n ϭ 5, respectively) (Fig. 1) . Monensin (10 M) potentiated the ACh-induced relaxation of phenylephrine-contracted rat aortic rings by 4 Ϯ 1%, 9 Ϯ 2%, and 19 Ϯ 4% at 10 Ϫ9 , 10 Ϫ8 , and 10
Ϫ7
M ACh concentration, respectively (P Ͻ 0.05) (Fig. 1) . The NO donor sodium nitroprusside (0.05 mM) totally relaxed the aortic rings (98 Ϯ 2%). Sodium nitroprusside-induced relaxation was affected neither by the Na ϩ ionophore monensin nor by the NCX inhibitors benzamil or KB-R7943 (data not shown). The vehicle ethanol (0.01%) had no effect on both phenylephrineinduced contraction and ACh-stimulated relaxation. 
Effect of the NCX inhibitors benzamil or KB-R7943 on monensin potentiation of ACh-induced relaxation.
Benzamil (1 mM) slightly decreased the ACh-induced relaxation of rat aortic rings. Preincubation with benzamil (1 mM) inhibited the monensin-dependent potentiation of ACh-induced relaxation [pD 2 ϭ 6.53 Ϯ 0.18, n ϭ 5 (P Ͻ 0.05); Fig. 2A ]. Neither monensin nor benzamil had an additional contracting effect on phenylephrine-precontracted rings (data not shown). Furthermore, neither monensin nor benzamil affected the response of endothelium-denuded aortic rings. Indeed, KB-R7943 (1 M) had no significant effect on AChinduced relaxation of rat aortic rings (Fig. 2B) . However, preincubation with KB-R7943 (1 M) inhibited the monensin-dependent potentiation of ACh-induced relaxation (pD 2 ϭ 6.56 Ϯ 0.04, n ϭ 4). Calibration of the NO sensor. The electrode was calibrated by decomposition of SNAP (Fig. 3) . The NO sensor was immersed in saturated CuCl solution. After stabilization, known volumes of the SNAP solution (for final concentrations of 10, 20, 50, 100, and 200 nM) were then added, and the response was monitored. Measurements of NO were performed under constant stirring in glass vials sealed with a septum. Linear calibration curves were obtained from the resulting calibration plot. The NO sensor responded straight away to SNAP addition. Steady state was reached in Ͻ3 s. The output current of the probe correlated linearly with the concentration of NO, current (in pA) ϭ 1.29 NO concentration ϩ 0.13 (P Ͻ 0.001).
Effect of the Na ϩ ionophore monensin on NO production. In PAECs, A-23187 (0.01-100 M) and bradykinin (0.001-10 M) induced NO release [pD 2 ϭ 5.21 Ϯ 0.09 (Fig. 4A ) and 6.17 Ϯ 0.30 (Fig. 4B) , respectively]. Preincubation with L-NAME (0.05 mM) totally inhibited the agonist-induced NO release. Monensin (1 and 10 M) shifted the concentration response curve of A-23187-and bradykinin-induced NO release to the right [pD 2 ϭ 5.66 Ϯ 0.15 ( Fig. 4A ) and 6.69 Ϯ 0.27 ( Fig.  4B) , respectively, for 1 M monensin and pD 2 ϭ 5.67 Ϯ 0.19 ( Fig. 4A ) and 6.72 Ϯ 0.24 ( Fig. 4B) , respectively, for 10 M monensin]. Monensin (1 and 10 M) increased by 8.9 Ϯ 0.5% and 26 Ϯ 5% the A-23187 (10 M)-evoked NO production and increased by 7.8 Ϯ 0.4% and 24 Ϯ 6% the bradykinin (1 M)-evoked NO production. Low concentration of Na ϩ (119 vs. 151 mM) did not modify the bradykinin-induced NO release; only Na ϩ -free buffer could activate NCX in reverse mode and potentiate NO release (data not shown).
Effect of benzamil and KB-R7943 on monensin-dependent NO production potentiation. Benzamil (1 mM) slightly decreased A-23187-and bradykinin-induced NO release (pD 2 ϭ 5.19 Ϯ 0.14 and 6.13 Ϯ 0.23, respectively; Fig. 5 ). Interestingly, pretreatment of endothelial cells with benzamil (1 mM) resulted in the inhibition of the monensin (10 M)-dependent potentiation of NO release induced by A-23187 and bradykinin [pD 2 ϭ 5.24 Ϯ 0.21 (P Ͻ 0.05) and 6.31 Ϯ 0.18 (P Ͻ 0.05); Fig. 5, A and B, respectively] . Indeed, KB-R7943 (1 M) slightly decreased the bradykinin-induced NO release (pD 2 ϭ 6.11 Ϯ 0.14) and inhibited the monensin (10 M)-dependent potentiation of the bradykinin-induced NO release (pD 2 ϭ 6.18 Ϯ 0.11; Fig. 5C ). Figure 6 shows examples of response of bradykininstimulated PAECs either preincubated with monensin or preincubated with monensin ϩ benzamil. The same results were obtained with A-23187 (data not shown).
DISCUSSION
According to the hypothesis that endothelial subplasmalemmal [Ca 2ϩ ] i was controlled by NCX (10), we studied the involvement of NCX in Ca 2ϩ -calmodulindependent eNOS activation. The role of NCX was investigated though modification of Na ϩ intracellular concentration with the Na ϩ ionophore monensin or through inhibition of NCX with the selective inhibitors benzamil and KB-R7943 on rat aortic rings or cultured PAECs. Our results are consistent with the involvement of NCX in endothelium-dependent relaxation. Na ϩ load induced by monensin potentiated AChevoked relaxation of the rat aorta and increased the Ca 2ϩ ionophore A-23187-and bradykinin-induced NO release by PAECs. Both NCX inhibitors antagonized these effects. NCX inhibitors alone slightly decreased agonist-induced endothelium-dependent relaxation and endothelial cell NO release.
Involvement of NCX in NO release. NO release measured with the amperometric electrode in response to A-23187 or bradykinin was in the nanomolar range. These low concentrations are in accordance with those of previous studies using cultured endothelial cells or endothelium-intact vessels (36, 39, 40) . The short halflife may be explained by the oxygenation of the buffer. Superoxide anions generated in oxygenated buffer may react with NO and decrease NO concentration (2, 12, 27) . The specificity of the NO sensor was documented by the inhibition of NO release by the NOS inhibitor L-NAME. The inhibitory effect of benzamil or KB-R7943 on the leftward shift of the NO concentrationresponse curve induced by monensin confirms the contribution of NCX in cultured endothelial cell NO release. These findings are consistent with those of Teubl et al. (37) , suggesting that Na ϩ /Ca 2ϩ exchange promotes Ca 2ϩ -dependent activation of eNOS. Furthermore, the NCX-dependent NO synthesis pathway was corroborated by the inhibition of the monensininduced potentiation of NO release by the NCX inhibitors benzamil and KB-R7943. The potential involvement of Na ϩ /H ϩ exchange in increased intracellular Potentiation of NO-dependent relaxation by the Na ϩ ionophore monensin. In rat aortic rings, Na ϩ load induced by monensin caused a leftward shift of the concentration-response curve to ACh. This result might relate to 1) direct potentiation of eNOS by an increase in intracellular Na ϩ concentration, 2) induction of the Ca 2ϩ release from intracellular Ca 2ϩ stores by monensin-induced Na ϩ entry, and 3) promotion of Ca 2ϩ entry in caveolae via NCX in reverse mode. eNOS has not been described to be Na ϩ dependent. However, Na ϩ load might relax rat aortic rings by the Ca 2ϩ -independent eNOS pathway or EDHF. Involvement of EDHF is unlikely, because endothelial Na ϩ entry is more likely to depolarize than to hyperpolarize the cells. Furthermore, Teubl et al. (37) have previously shown that membrane depolarization was not involved in eNOS activation. Alternatively, Laskey et al. (17) and Groschner et al. (11) have shown that Na ϩ loading decreased store-operated Ca 2ϩ entry via decreased electrochemical gradient. These results suggest that potentiation of eNOS activation by the Na ϩ ionophore monensin was independent from intracellular Ca 2ϩ stores release. Therefore, the main hypothesis remains the involvement of NCX. Na ϩ loading allowed for Ca 2ϩ entry via NCX in reverse mode (18, 32) . Because eNOS is mainly dependent from Ca 2ϩ /calmodulin, our results suggest that monensin potentiates NO-dependent relaxation by increasing the caveolae Ca 2ϩ concentration. These findings are consistent with previous results showing that NCX increase Ca 2ϩ -dependent activation of eNOS (37) . The authors hypothesized that NCX might increase subplasmalemmal [Ca 2ϩ ] i , because eNOS and NCX were codistributed in caveolae; they concluded that Na ϩ load promotes NOS III activation without increasing overall [Ca 2ϩ ] i . The role of NCX in reverse mode was corroborated by the effect of the specific NCX inhibitors benzamil and KB-R7943 on endotheliumdependent relaxation. A previous study has reported that amiloride, an inhibitor of Na ϩ /Ca 2ϩ exchange, blunted ACh-stimulated increases in tissue cGMP levels. The presence of amiloride had no effect on increases in cGMP levels evoked by the NO donor sodium nitroprusside (33) . Additionally, increasing concentrations of dichlorobenzamil functionally antagonized the relaxation elicited by ACh and A-23187 but had no effect on the sodium nitroprusside-dependent relaxation (41) . All in all, NCX in reverse mode potentiated NO-dependent relaxation. In physiological conditions, NCX seems to extrude Ca 2ϩ to prevent Ca 2ϩ overload, whereas in pathological conditions, NCX increases Ca 2ϩ in caveolae and promotes NO synthesis. Our results with low-Na ϩ buffer, in concert with those of Teubl et al. (37) , suggest that only hyponatremia down to 100 mM may activate eNOS via NCX in reverse mode. The role of NCX functioning in forward mode remains, however, to be investigated.
In conclusion, our findings suggest that NCX in reverse mode may increase subplasmalemmal Ca 2ϩ concentration and promote the Ca 2ϩ /calmodulin complex. Therefore, the binding of Ca 2ϩ /calmodulin to eNOS shifts the caveolin-1-eNOS balance and induces NO synthesis. The involvement of NCX in NO-dependent relaxation has particular relevance in low-Na ϩ extracellular medium, and the development of a specific endothelial NCX inhibitor may provide new tools for the study of vascular tone control.
